Black Friday Sale! Save huge on InvestingProGet up to 60% off

NZ batsman Taylor to face Pakistan prior to eye surgery

Published 23/11/2016, 06:43
© Reuters. Cricket - New Zealand v Pakistan - World Twenty20 cricket tournament

WELLINGTON (Reuters) - New Zealand's Ross Taylor has passed an eye test and will be available to face Pakistan but the batsman plans to undergo surgery on a benign growth of the conjunctiva after the match and faces six weeks on the sidelines.

Taylor did not bat in the second innings of the series-opening test in Christchurch after having an preliminary eye test on the first day and was a doubt for the second match at Seddon Park in Hamilton starting on Friday.

After New Zealand wrapped up victory on Sunday, coach Mike Hesson said the 32-year-old former skipper had experienced a problem with vision out of the eye for about a year and a test showed it may have deteriorated "quicker" than hoped.

However, a second eye examination in Hamilton returned a more positive prognosis.

"Ross has a pterygium on his left eye, which is gradually getting bigger. Both the specialists he's seen in recent days have advised Ross still has 20/20 vision and Ross himself feels confident he is ready to play," team physiotherapist Tommy Simsek said in a media release.

© Reuters. Cricket - New Zealand v Pakistan - World Twenty20 cricket tournament

"Ross will still need to undergo a medical procedure on his eye to remove the pterygium before it gets any larger. He'll have surgery following the test which rule him out of cricket for approximately four-to-six weeks."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.